VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 187 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $256,584 | -14.0% | 60,802 | -11.9% | 0.01% | -18.2% |
| Q3 2023 | $298,192 | -3.6% | 69,026 | +47.0% | 0.01% | 0.0% |
| Q2 2023 | $309,472 | +123.9% | 46,961 | +130.7% | 0.01% | +120.0% |
| Q1 2023 | $138,217 | +70418.9% | 20,356 | -23.3% | 0.01% | -37.5% |
| Q4 2022 | $196 | -99.9% | 26,532 | +75.7% | 0.01% | +14.3% |
| Q3 2022 | $149,000 | +10.4% | 15,100 | +47.5% | 0.01% | +40.0% |
| Q4 2020 | $135,000 | +36.4% | 10,239 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $99,000 | – | 10,239 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |